Venom of marine snails provide new drugs

Feb 17, 2011

Baldomero Olivera studies chemical compounds found in the venoms of marine cone snails, a potential source of powerful, yet safe and effective drugs. He will discuss the development of Prialt - an FDA-approved drug for intractable, chronic pain - and the potential for new drugs during a free public lecture at the University of Utah.

The conventional picture of a snail is a slow-moving, plant-eating, shelled animal found in gardens. However, in the marine environment, there are more than 100,000 species of snails. About 100 different species have evolved to become venomous predators that specialize in hunting fish. These fish-hunting Conus harpoon fish with a hypodermic needle-like tooth that injects paralyzing made up of 100 chemical components.

"The long-range goal is to use these toxins as an entrée for studying key molecules in the central ," Olivera says.

The fact that the poisons can be synthesized and categorized easily will enable researchers to learn more about parts of the nervous system affected by the Conus toxins.

The precise mechanism that accounts for the biological activity of most peptides present in cone snail venoms has not yet been determined. A major challenge in the next few years is to clarify the molecular mechanisms through which the different peptides in Conus venom elicit their profound behavioral effects.

The natural form of Prialt - a drug for severe pain approved in 2004 by the U.S. Food and Drug Administration - was discovered in Olivera's lab in 1979 by J. Michael McIntosh, then an incoming freshman at the University of Utah and now a professor of psychiatry and research professor of biology. The drug was isolated from the fish-hunting cone snail Conus magus, or magician's cone, which is only 1.5 inches long.

Prialt is injected into the fluid surrounding the spinal cord to treat chronic, intractable pain suffered by people with cancer, AIDS, injury, failed back surgery or certain nervous system disorders.

Olivera was named a distinguished professor of biology at the University of Utah in 1992. He is the author of more than 250 scientific publications. In 2006, he was appointed a Howard Hughes Medical Institute Professor. He was elected to the Institute of Medicine in 2007 and to the National Academy of Sciences in 2009.

Explore further: A new synthetic amino acid for an emerging class of drugs

add to favorites email to friend print save as pdf

Related Stories

Snail toxins reveal novel way to fight severe nerve pain

Nov 13, 2006

A brand new approach to treating severe nerve pain – by aiming drugs at a previously unrecognized molecular target – has been discovered by University of Utah scientists who study the venoms of deadly, ...

Snail venoms reflect reduced competition

May 20, 2009

A study of venomous snails on remote Pacific islands reveals genetic underpinnings of an ecological phenomenon that has fascinated scientists since Darwin.

Recommended for you

Scientists make diseased cells synthesize their own drug

4 hours ago

In a new study that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have adapted a chemical approach to turn diseased cells into unique manufacturing ...

A new synthetic amino acid for an emerging class of drugs

Aug 31, 2014

Swiss scientists have developed a new amino acid that can be used to modify the 3-D structure of therapeutic peptides. Insertion of the amino acid into bioactive peptides enhanced their binding affinity up to 40-fold. Peptides ...

User comments : 0